{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:54:57Z","timestamp":1778745297663,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"9744","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/s0140-6736(10)61198-1","type":"journal-article","created":{"date-parts":[[2010,8,31]],"date-time":"2010-08-31T06:58:16Z","timestamp":1283237896000},"page":"875-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2109,"title":["Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study"],"prefix":"10.1016","volume":"376","clinical-trial-number":[{"clinical-trial-number":"isrctn70429960","registry":"10.18810\/isrctn"}],"author":[{"given":"Karl","family":"Swedberg","sequence":"first","affiliation":[]},{"given":"Michel","family":"Komajda","sequence":"additional","affiliation":[]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[]},{"given":"Jeffrey S","family":"Borer","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[]},{"given":"Ariane","family":"Dubost-Brama","sequence":"additional","affiliation":[]},{"given":"Guy","family":"Lerebours","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Tavazzi","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(10)61198-1_bib10","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.ejheart.2008.08.005","volume":"10","author":"Dickstein","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S0140-6736(10)61198-1_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1161\/CIRCULATIONAHA.108.812172","article-title":"Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people","volume":"119","author":"Jhund","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(10)61198-1_bib30","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehn541","article-title":"Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987\u20132003 from the Swedish Hospital Discharge Registry","volume":"30","author":"Shafazand","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib40","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/01.CIR.0000065187.80707.18","article-title":"Beta-blockers in chronic heart failure","volume":"107","author":"Gheorghiade","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(10)61198-1_bib50","doi-asserted-by":"crossref","first-page":"43B","DOI":"10.1016\/j.amjcard.2004.01.025","article-title":"Ventricular remodeling in heart failure and the effect of beta-blockade","volume":"93","author":"Udelson","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(10)61198-1_bib60","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)61198-1_bib70","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":"Heart rate and cardiac rhythm relationships with bisoprolol benefit in chronic heart failure in CIBIS II Trial","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(10)61198-1_bib80","doi-asserted-by":"crossref","first-page":"784","DOI":"10.7326\/0003-4819-150-11-200906020-00006","article-title":"Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure","volume":"150","author":"McAlister","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0140-6736(10)61198-1_bib90","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(89)90386-X","article-title":"The myocardium in congestive heart failure","volume":"3","author":"Katz","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(10)61198-1_bib100","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehi190","article-title":"Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease","volume":"26","author":"Diaz","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.eurheartj.a062065","article-title":"The multifactor primary prevention trial in G\u00f6teborg, Sweden","volume":"7","author":"Wilhelmsen","year":"1986","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib120","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)61198-1_bib130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/eurheartj\/ehi555","article-title":"Predictors of mortality and morbidity in patients with chronic heart failure","volume":"27","author":"Pocock","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib140","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjcard.2007.11.023","article-title":"Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers","volume":"101","author":"Flannery","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0140-6736(10)61198-1_bib150","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0195-668X(02)00700-5","article-title":"The EuroHeart Failure Survey programme\u2014a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment","volume":"24","author":"Komajda","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib160","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.phrs.2006.03.006","article-title":"Funny channels in the control of cardiac rhythm and mode of action of selective blockers","volume":"53","author":"DiFrancesco","year":"2006","journal-title":"Pharmacol Res"},{"key":"10.1016\/S0140-6736(10)61198-1_bib170","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00002018-200831020-00001","article-title":"If inhibition with ivabradine: electrophysiological effects and safety","volume":"31","author":"Savelieva","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/S0140-6736(10)61198-1_bib180","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/eurjhf\/hfp154","article-title":"Rationale and design of a randomized, double-blind, placebo-controlled outcome trial of ivabradine in chronic heart failure: the Systolic Heart Failure Treatment with the I(f) Inhibitor Ivabradine Trial (SHIFT)","volume":"12","author":"Swedberg","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S0140-6736(10)61198-1_bib190","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/eurheartj\/ehi204","article-title":"Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology","volume":"26","author":"Swedberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S0140-6736(10)61198-1_bib200","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/0140-6736(93)92930-R","article-title":"Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy","volume":"342","author":"Waagstein","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)61198-1_bib210","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ejheart.2007.09.008","article-title":"Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey","volume":"9","author":"de Groote","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S0140-6736(10)61198-1_bib220","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/eurjhf\/hfn006","article-title":"Adequacy of diagnosis and treatment of chronic heart failure in primary health care in Sweden","volume":"11","author":"Dahlstrom","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S0140-6736(10)61198-1_bib230","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.jacc.2008.07.056","article-title":"Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program","volume":"52","author":"Blair","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0140-6736(10)61198-1_bib240","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(08)61170-8","article-title":"Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(10)61198-1_bib250","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(10)61198-1_bib260","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ahj.2004.10.002","article-title":"Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure\u2014COMET","volume":"149","author":"Torp-Pedersen","year":"2005","journal-title":"Am Heart J"}],"updated-by":[{"DOI":"10.1016\/s0140-6736(10)62264-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,12,11]],"date-time":"2010-12-11T00:00:00Z","timestamp":1292025600000}}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610611981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673610611981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T23:58:46Z","timestamp":1758844726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673610611981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":26,"journal-issue":{"issue":"9744","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0140673610611981"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(10)61198-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7376958.7649057","asserted-by":"object"}]},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"The Lancet","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(10)61198-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(10)61314-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(10)61259-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}